Science Explorer Back to mapMap
Discussion
Company · Lausanne · Switzerland

Debiopharm (Switzerland)

debiopharm.comROR OpenAlex
World rank, all time
#34,425
of 34,923
Rank in Switzerland
#377
of 378
Research works
126
▲ 127% vs 2018-21
Citations
2.7k
21.3 per fractional work
Top-10% rate
12.0%
all institutions 10.0%
vs its own fields
0.94×
1.00× is exactly expected
Open access
40%
world 40%
International
61%
world 18%
Debiopharm (Switzerland)

Which fields of science does Debiopharm (Switzerland) work in?

In 2022-now, 49% of research at Debiopharm (Switzerland) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (30%), Agricultural and Biological Sciences (3%). It does 2.3× the world's share of Life Sciences.

Health Sciences: 23 fractional works · 49.2% of its workMedicine: 22 fractional works · 47.7% of its workOncology: 7 fractional works · 15.4% of its workInfectious Diseases: 3 fractional works · 6.0% of its workRadiology, Nuclear Medicine and Imaging: 3 fractional works · 5.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.0% of its workEpidemiology: 1 fractional works · 2.4% of its workHematology: 1 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.7% of its workGenetics: 1 fractional works · 1.5% of its workPhysiology: 1 fractional works · 1.5% of its workSurgery: 1 fractional works · 1.2% of its workOtorhinolaryngology: 1 fractional works · 1.1% of its workNeurology: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.9% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.5% of its workDermatology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workVeterinary: 1 fractional works · 1.1% of its workSmall Animals: 1 fractional works · 1.1% of its workHealth Professions: 0 fractional works · 0.4% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workLife Sciences: 18 fractional works · 39.3% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 30.5% of its workMolecular Biology: 12 fractional works · 24.9% of its workPhysiology: 1 fractional works · 1.5% of its workGenetics: 1 fractional works · 1.3% of its workBiotechnology: 0 fractional works · 0.7% of its workMolecular Medicine: 0 fractional works · 0.6% of its workCancer Research: 0 fractional works · 0.5% of its workBiophysics: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 3.2% of its workAgronomy and Crop Science: 1 fractional works · 1.3% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.5% of its workPharmaceutical Science: 1 fractional works · 1.9% of its workPharmacology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 1.6% of its workImmunology: 0 fractional works · 0.6% of its workMicrobiology: 0 fractional works · 0.6% of its workVirology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 1.5% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.2% of its workNeurology: 0 fractional works · 0.4% of its workPhysical Sciences: 3 fractional works · 6.8% of its workChemistry: 1 fractional works · 2.5% of its workOrganic Chemistry: 1 fractional works · 1.7% of its workSpectroscopy: 0 fractional works · 0.8% of its workComputer Science: 1 fractional works · 1.6% of its workComputational Theory and Mathematics: 1 fractional works · 1.6% of its workEnvironmental Science: 0 fractional works · 0.7% of its workEcology: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 0 fractional works · 0.7% of its workBiomaterials: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workComputational Mechanics: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workRadiation: 0 fractional works · 0.4% of its workChemical Engineering: 0 fractional works · 0.2% of its workFluid Flow and Transfer Processes: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 4.7% of its workBusiness, Management and Accounting: 1 fractional works · 1.9% of its workManagement Information Systems: 0 fractional works · 0.7% of its workAccounting: 0 fractional works · 0.6% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.4% of its workManagement of Technology and Innovation: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.5% of its workEconomics and Econometrics: 1 fractional works · 1.1% of its workFinance: 0 fractional works · 0.4% of its workSocial Sciences: 1 fractional works · 1.3% of its workGender Studies: 0 fractional works · 0.6% of its workDemography: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.4% of its workALL ITS WORKDebiopharm(Switzerland)46fractional works, 2022-now
Life Sciences39%Physical Sciences7%Health Sciences49%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine2247.7%
    2. Veterinary11.1%
    3. Health Professions00.4%
    1. Biochemistry, Genetics and Molecular Biology1430.5%
    2. Agricultural and Biological Sciences13.2%
    3. Pharmacology, Toxicology and Pharmaceutics12.5%
    4. Immunology and Microbiology11.6%
    5. Neuroscience11.5%
    1. Chemistry12.5%
    2. Computer Science11.6%
    3. Environmental Science00.7%
    4. Materials Science00.7%
    5. Engineering00.6%
    6. Physics and Astronomy00.4%
    7. Chemical Engineering00.2%
    1. Business, Management and Accounting11.9%
    2. Economics, Econometrics and Finance11.5%
    3. Social Sciences11.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.67× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.72× its world share, 14 worksBiochemistry, Geneti…Immunology and Microbiology: 1.58× its world share, 1 worksImmunology and Micro…Neuroscience: 0.95× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.07× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.69× its world share, 0 worksChemical EngineeringChemistry: 1.60× its world share, 1 worksChemistryComputer Science: 0.21× its world share, 1 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.20× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.16× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.14× its world share, 0 worksHealth ProfessionsMedicine: 2.48× its world share, 22 worksMedicineVeterinary: 8.09× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.60× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 0.70× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.10× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 8.1×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Veterinary8.09×0 works
  2. Pharmacology, Toxicology and Pharmaceutics7.07×1 works
  3. Biochemistry, Genetics and Molecular Biology5.72×14 works
  4. Medicine2.48×22 works
  5. Chemistry1.60×1 works
  6. Immunology and Microbiology1.58×1 works
  7. Neuroscience0.95×1 works
  8. Economics, Econometrics and Finance0.70×1 works
  9. Chemical Engineering0.69×0 works
  10. Agricultural and Biological Sciences0.67×2 works
  11. Business, Management and Accounting0.60×1 works
  12. Computer Science0.21×1 works
  13. Materials Science0.20×0 works
  14. Physics and Astronomy0.16×0 works
  15. Environmental Science0.15×0 works
  16. Health Professions0.14×0 works
  17. Social Sciences0.10×1 works
  18. Engineering0.04×0 works

Who are the top researchers at Debiopharm (Switzerland)?

Ranked on the quality score, Léo Marx, Anne Vaslin Chessex and Claudio Zanna lead among researchers whose main affiliation is Debiopharm (Switzerland).

  1. 1 Léo Marx Switzerland · #495,067 worldwide 4.7k citations · 115 works
  2. 2 Anne Vaslin Chessex Switzerland · #837,104 worldwide 436 citations · 62 works
  3. 3 Claudio Zanna Switzerland · #911,422 worldwide 2k citations · 106 works
  4. 4 Grégoire Vuagniaux Switzerland · #1,180,404 worldwide 2.8k citations · 87 works
  5. 5 Valerie Nicolas‐Métral Switzerland · #1,351,238 worldwide 1.3k citations · 32 works
  6. 6 Franck Brichory Switzerland · #1,354,050 worldwide 1.5k citations · 32 works
  7. 7 Jean‐Maurice Dumont Switzerland · #1,364,911 worldwide 1.4k citations · 18 works
  8. 8 Anna Pokorska-Bocci Switzerland · #1,385,273 worldwide 432 citations · 46 works
  9. 9 Heidi Nauwelaerts Switzerland · #1,453,716 worldwide 530 citations · 22 works
  10. 10 Bruno Gavillet Switzerland · #1,481,173 worldwide 1.6k citations · 50 works
All ranked researchers at Debiopharm (Switzerland)

What are the most cited papers from Debiopharm (Switzerland)?

The most cited paper from Debiopharm (Switzerland) is "Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data" (Julie-Anne Quinn, Flor M. Muñoz, Bernard Gonik et al., 2016), with 508 citations. Next come "Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines" (435) and "Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy" (359).

Most cited papers
#PaperReleasedCitations
1 Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data Julie-Anne Quinn, Flor M. Muñoz, Bernard Gonik et al. · Vaccine Open access 16 Oct 2016 508
2 Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology Open access 1996 435
3 Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy Douglas P. Millay, Michelle A. Sargent, Hanna E. Osińska et al. · Nature Medicine Open access 16 Mar 2008 359
4 Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives Elidie Béard, Sylvain Lengacher, Sara Dias et al. · Frontiers in Physiology Open access 10 Jan 2022 317
5 Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat Guido Cavaletti, G Tredici, M G Petruccioli et al. · European Journal of Cancer Dec 2001 289
All 60 most cited papers, with filters and sorting

Which keywords describe research at Debiopharm (Switzerland)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Therapy, Chemotherapy, Epidemiology, Cell Death, Medicinal Chemistry, Immune Response, Monoclonal Antibody and Metastatic.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Therapy5▲ 20×15 topics
  2. Epidemiology4▲ 2.3×21 topics
  3. Chemotherapy4▲ 12×11 topics
  4. Inflammation2▲ 2.5×10 topics
  5. Cell Death2▲ 20×4 topics
  6. Medicinal Chemistry2▲ 18×5 topics
  7. Cancer2▲ 3.4×12 topics
  8. Immune Response2▲ 7.9×5 topics
  9. Immunotherapy2▲ 6.0×8 topics
  10. Monoclonal Antibody2▲ 80×2 topics
  11. Breast Cancer2▲ 16×1 topic
  12. HER22▲ 129×1 topic
  13. Metastatic2▲ 63×2 topics
  14. Tumor Microenvironment2▲ 9.1×6 topics
  15. Apoptosis2▲ 12×5 topics
  16. SARS-CoV-22▲ 12×4 topics
  17. Genome Engineering2▲ 55×1 topic
  18. Mitochondria2▲ 26×2 topics
  19. Monoclonal Antibodies2▲ 38×3 topics
  20. RNA-Guided2▲ 55×1 topic
  21. Reactive Oxygen Species2▲ 8.4×2 topics
  22. Targeted Therapy2▲ 16×4 topics
  23. Therapeutic Antibodies2▲ 48×2 topics
  24. Clinical Trials2▲ 4.8×6 topics
  25. Glycosylation1▲ 28×2 topics
  26. Prognostic Factors1▲ 6.8×6 topics
  27. Antibody Engineering1▲ 53×1 topic
  28. Antimicrobial Resistance1▲ 14×3 topics
  29. Drug Discovery1▲ 13×3 topics
  30. Fc Receptors1▲ 53×1 topic
  31. Healthcare-Associated Infections1▲ 22×2 topics
  32. PET Imaging1▲ 17×4 topics
  33. Metabolic Regulation1▲ 15×2 topics
  34. Pharmacokinetics1▲ 9.5×3 topics
  35. Vaccine1▲ 6.3×3 topics
  36. ACE2 Receptor1▲ 10×2 topics
  37. Bcl-2 Family1▲ 160×1 topic
  38. Inhibitors1▲ 55×2 topics
  39. Neuroprotection1▲ 6.9×4 topics
  40. TNF Signaling1▲ 160×1 topic

Which research topics does Debiopharm (Switzerland) publish most on?

By volume in 2022-now: HER2/EGFR in Cancer Research, CRISPR and Genetic Engineering, Monoclonal and Polyclonal Antibodies Research and Cell death mechanisms and regulation.

HER2/EGFR in Cancer Research: 2 fractional worksCRISPR and Genetic Engineering: 2 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksCell death mechanisms an…1Cell death mechanisms and regulation: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksAntimicrobial Resistance in Staphylococcus: 1 fractional worksComputational Drug Disco…1Computational Drug Discovery Methods: 1 fractional worksPI3K/AKT/mTOR signaling …1PI3K/AKT/mTOR signaling in cancer: 1 fractional worksAdvanced Biosensing Tech…1Advanced Biosensing Techniques and Applications: 1 fractional worksDrug Transport and Resis…1Drug Transport and Resistance Mechanisms: 1 fractional works
OncologyMolecular BiologyRadiology, Nuclear Medicine and ImagingInfectious Diseases1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 2 works
  2. 2 CRISPR and Genetic Engineering Molecular Biology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Cell death mechanisms and regulation Molecular Biology 1 works
  5. 5 Cancer Treatment and Pharmacology Oncology 1 works
  6. 6 Antimicrobial Resistance in Staphylococcus Infectious Diseases 1 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  8. 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works
  9. 9 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
  10. 10 Drug Transport and Resistance Mechanisms Oncology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.3%not open59.7%

World: 40% of research is openly available.

with international co-authors61.2%domestic only38.8%

World: 18% is written across borders.

How has Debiopharm (Switzerland)'s research output changed?

Output in 2022-2025 was 127% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Debiopharm (Switzerland) as a percentage of every work published that year, 0.00021% in 2024.

still counting0.00010%0.00020%0.00030%Debiopharm (Switzerland)0.00022% in 202519801990200020102020

Fractional works of Debiopharm (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lausanne

All research institutions in Lausanne

Share Debiopharm (Switzerland)'s ranking

Debiopharm (Switzerland) on Science Explorer

A card with Debiopharm (Switzerland)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Debiopharm (Switzerland). Posts are plain text and can be reported.